-
1
-
-
33746763724
-
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
-
10.1586/14760584.5.3.347, 2716009, 16827619
-
Haynes BF, Montefiori DC. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev Vaccines 2006, 5:347-363. 10.1586/14760584.5.3.347, 2716009, 16827619.
-
(2006)
Expert Rev Vaccines
, vol.5
, pp. 347-363
-
-
Haynes, B.F.1
Montefiori, D.C.2
-
2
-
-
38949170716
-
Prospects of HIV Env modification as an approach to HIV vaccine design
-
10.2174/157016207782418542, 18045108
-
Hu SL, Stamatatos L. Prospects of HIV Env modification as an approach to HIV vaccine design. Curr HIV Res 2007, 5:507-513. 10.2174/157016207782418542, 18045108.
-
(2007)
Curr HIV Res
, vol.5
, pp. 507-513
-
-
Hu, S.L.1
Stamatatos, L.2
-
3
-
-
33846172297
-
Rational modifications of HIV-1 envelope glycoproteins for immunogen design
-
10.2174/138161207779313632, 17269929
-
Phogat S, Wyatt R. Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr Pharm Des 2007, 13:213-227. 10.2174/138161207779313632, 17269929.
-
(2007)
Curr Pharm Des
, vol.13
, pp. 213-227
-
-
Phogat, S.1
Wyatt, R.2
-
4
-
-
1542317452
-
HIV vaccine design and the neutralizing antibody problem
-
10.1038/ni0304-233, 14985706
-
Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004, 5:233-236. 10.1038/ni0304-233, 14985706.
-
(2004)
Nat Immunol
, vol.5
, pp. 233-236
-
-
Burton, D.R.1
Desrosiers, R.C.2
Doms, R.W.3
Koff, W.C.4
Kwong, P.D.5
Moore, J.P.6
Nabel, G.J.7
Sodroski, J.8
Wilson, I.A.9
Wyatt, R.T.10
-
5
-
-
38349081511
-
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
-
10.1038/nrmicro1819, 18197170
-
Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 2008, 6:143-155. 10.1038/nrmicro1819, 18197170.
-
(2008)
Nat Rev Microbiol
, vol.6
, pp. 143-155
-
-
Karlsson Hedestam, G.B.1
Fouchier, R.A.2
Phogat, S.3
Burton, D.R.4
Sodroski, J.5
Wyatt, R.T.6
-
6
-
-
33847101745
-
Structural definition of a conserved neutralization epitope on HIV-1 gp120
-
10.1038/nature05580, 2584968, 17301785
-
Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007, 445:732-737. 10.1038/nature05580, 2584968, 17301785.
-
(2007)
Nature
, vol.445
, pp. 732-737
-
-
Zhou, T.1
Xu, L.2
Dey, B.3
Hessell, A.J.4
Van Ryk, D.5
Xiang, S.H.6
Yang, X.7
Zhang, M.Y.8
Zwick, M.B.9
Arthos, J.10
Burton, D.R.11
Dimitrov, D.S.12
Sodroski, J.13
Wyatt, R.14
Nabel, G.J.15
Kwong, P.D.16
-
7
-
-
33748896583
-
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
-
10.1097/01.aids.0000247113.43714.5e, 16988513
-
Braibant M, Brunet S, Costagliola D, Rouzioux C, Agut H, Katinger H, Autran B, Barin F. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. Aids 2006, 20:1923-1930. 10.1097/01.aids.0000247113.43714.5e, 16988513.
-
(2006)
Aids
, vol.20
, pp. 1923-1930
-
-
Braibant, M.1
Brunet, S.2
Costagliola, D.3
Rouzioux, C.4
Agut, H.5
Katinger, H.6
Autran, B.7
Barin, F.8
-
8
-
-
0037083960
-
Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1
-
10.1097/00002030-200202150-00030, 11834970
-
Donners H, Willems B, Beirnaert E, Colebunders R, Davis D, van der Groen G. Cross-neutralizing antibodies against primary isolates in African women infected with HIV-1. Aids 2002, 16:501-503. 10.1097/00002030-200202150-00030, 11834970.
-
(2002)
Aids
, vol.16
, pp. 501-503
-
-
Donners, H.1
Willems, B.2
Beirnaert, E.3
Colebunders, R.4
Davis, D.5
van der Groen, G.6
-
9
-
-
34249940652
-
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
-
10.1128/JVI.00239-07, 1900112, 17409164, CAPRISA 002 Study Team
-
Gray ES, Moore PL, Choge IA, Decker JM, Bibollet-Ruche F, Li H, Leseka N, Treurnicht F, Mlisana K, Shaw GM, Karim SS, Williamson C, Morris L, . CAPRISA 002 Study Team Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol 2007, 81:6187-6196. 10.1128/JVI.00239-07, 1900112, 17409164, CAPRISA 002 Study Team.
-
(2007)
J Virol
, vol.81
, pp. 6187-6196
-
-
Gray, E.S.1
Moore, P.L.2
Choge, I.A.3
Decker, J.M.4
Bibollet-Ruche, F.5
Li, H.6
Leseka, N.7
Treurnicht, F.8
Mlisana, K.9
Shaw, G.M.10
Karim, S.S.11
Williamson, C.12
Morris, L.13
-
10
-
-
33646751914
-
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1
-
10.1128/JVI.00201-06, 1472127, 16699001
-
Li B, Decker JM, Johnson RW, Bibollet-Ruche F, Wei X, Mulenga J, Allen S, Hunter E, Hahn BH, Shaw GM, Blackwell JL, Derdeyn CA. Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol 2006, 80:5211-5218. 10.1128/JVI.00201-06, 1472127, 16699001.
-
(2006)
J Virol
, vol.80
, pp. 5211-5218
-
-
Li, B.1
Decker, J.M.2
Johnson, R.W.3
Bibollet-Ruche, F.4
Wei, X.5
Mulenga, J.6
Allen, S.7
Hunter, E.8
Hahn, B.H.9
Shaw, G.M.10
Blackwell, J.L.11
Derdeyn, C.A.12
-
11
-
-
0030901363
-
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
-
191523, 9094648
-
Moog C, Fleury HJ, Pellegrin I, Kirn A, Aubertin AM. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J Virol 1997, 71:3734-3741. 191523, 9094648.
-
(1997)
J Virol
, vol.71
, pp. 3734-3741
-
-
Moog, C.1
Fleury, H.J.2
Pellegrin, I.3
Kirn, A.4
Aubertin, A.M.5
-
12
-
-
0030764685
-
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection
-
10.1086/516508, 9333150
-
Pilgrim AK, Pantaleo G, Cohen OJ, Fink LM, Zhou JY, Zhou JT, Bolognesi DP, Fauci AS, Montefiori DC. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis 1997, 176:924-932. 10.1086/516508, 9333150.
-
(1997)
J Infect Dis
, vol.176
, pp. 924-932
-
-
Pilgrim, A.K.1
Pantaleo, G.2
Cohen, O.J.3
Fink, L.M.4
Zhou, J.Y.5
Zhou, J.T.6
Bolognesi, D.P.7
Fauci, A.S.8
Montefiori, D.C.9
-
13
-
-
0037389643
-
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
-
10.1073/pnas.0630530100, 153062, 12644702
-
Richman DD, Wrin T, Little SJ, Petropoulos CJ. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 2003, 100:4144-4149. 10.1073/pnas.0630530100, 153062, 12644702.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 4144-4149
-
-
Richman, D.D.1
Wrin, T.2
Little, S.J.3
Petropoulos, C.J.4
-
14
-
-
44949262146
-
Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses
-
10.1128/JVI.00389-08, 2395128, 18400850
-
Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu SL, Stamatatos L. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses. J Virol 2008, 82:5912-5921. 10.1128/JVI.00389-08, 2395128, 18400850.
-
(2008)
J Virol
, vol.82
, pp. 5912-5921
-
-
Kraft, Z.1
Strouss, K.2
Sutton, W.F.3
Cleveland, B.4
Tso, F.Y.5
Polacino, P.6
Overbaugh, J.7
Hu, S.L.8
Stamatatos, L.9
-
15
-
-
34948854718
-
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
-
10.1038/nm1624, 2584972, 17721546
-
Li Y, Migueles SA, Welcher B, Svehla K, Phogat A, Louder MK, Wu X, Shaw GM, Connors M, Wyatt RT, Mascola JR. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007, 13:1032-1034. 10.1038/nm1624, 2584972, 17721546.
-
(2007)
Nat Med
, vol.13
, pp. 1032-1034
-
-
Li, Y.1
Migueles, S.A.2
Welcher, B.3
Svehla, K.4
Phogat, A.5
Louder, M.K.6
Wu, X.7
Shaw, G.M.8
Connors, M.9
Wyatt, R.T.10
Mascola, J.R.11
-
16
-
-
0032546844
-
The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens
-
10.1126/science.280.5371.1884, 9632381
-
Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280:1884-1888. 10.1126/science.280.5371.1884, 9632381.
-
(1998)
Science
, vol.280
, pp. 1884-1888
-
-
Wyatt, R.1
Sodroski, J.2
-
17
-
-
0031969423
-
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity
-
109569, 9557629
-
Parren PW, Mondor I, Naniche D, Ditzel HJ, Klasse PJ, Burton DR, Sattentau QJ. Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J Virol 1998, 72:3512-3519. 109569, 9557629.
-
(1998)
J Virol
, vol.72
, pp. 3512-3519
-
-
Parren, P.W.1
Mondor, I.2
Naniche, D.3
Ditzel, H.J.4
Klasse, P.J.5
Burton, D.R.6
Sattentau, Q.J.7
-
18
-
-
0030726970
-
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
-
10.1084/jem.186.8.1287, 2199094, 9334368
-
Ugolini S, Mondor I, Parren PW, Burton DR, Tilley SA, Klasse PJ, Sattentau QJ. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J Exp Med 1997, 186:1287-1298. 10.1084/jem.186.8.1287, 2199094, 9334368.
-
(1997)
J Exp Med
, vol.186
, pp. 1287-1298
-
-
Ugolini, S.1
Mondor, I.2
Parren, P.W.3
Burton, D.R.4
Tilley, S.A.5
Klasse, P.J.6
Sattentau, Q.J.7
-
19
-
-
0141521564
-
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
-
10.1128/JVI.77.19.10557-10565.2003, 228502, 12970440
-
Labrijn AF, Poignard P, Raja A, Zwick MB, Delgado K, Franti M, Binley J, Vivona V, Grundner C, Huang CC, Venturi M, Petropoulos CJ, Wrin T, Dimitrov DS, Robinson J, Kwong PD, Wyatt RT, Sodroski J, Burton DR. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol 2003, 77:10557-10565. 10.1128/JVI.77.19.10557-10565.2003, 228502, 12970440.
-
(2003)
J Virol
, vol.77
, pp. 10557-10565
-
-
Labrijn, A.F.1
Poignard, P.2
Raja, A.3
Zwick, M.B.4
Delgado, K.5
Franti, M.6
Binley, J.7
Vivona, V.8
Grundner, C.9
Huang, C.C.10
Venturi, M.11
Petropoulos, C.J.12
Wrin, T.13
Dimitrov, D.S.14
Robinson, J.15
Kwong, P.D.16
Wyatt, R.T.17
Sodroski, J.18
Burton, D.R.19
-
20
-
-
33744904454
-
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses
-
10.1128/JVI.00093-06, 1472617, 16731954
-
Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol 2006, 80:6155-6164. 10.1128/JVI.00093-06, 1472617, 16731954.
-
(2006)
J Virol
, vol.80
, pp. 6155-6164
-
-
Deeks, S.G.1
Schweighardt, B.2
Wrin, T.3
Galovich, J.4
Hoh, R.5
Sinclair, E.6
Hunt, P.7
McCune, J.M.8
Martin, J.N.9
Petropoulos, C.J.10
Hecht, F.M.11
-
21
-
-
58149399396
-
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies
-
10.1128/JVI.01583-08, 2612342, 18922865
-
Doria-Rose NA, Klein RM, Manion MM, O'Dell S, Phogat A, Chakrabarti B, Hallahan CW, Migueles SA, Wrammert J, Ahmed R, Nason M, Wyatt RT, Mascola JR, Connors M. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies. J Virol 2009, 83:188-199. 10.1128/JVI.01583-08, 2612342, 18922865.
-
(2009)
J Virol
, vol.83
, pp. 188-199
-
-
Doria-Rose, N.A.1
Klein, R.M.2
Manion, M.M.3
O'Dell, S.4
Phogat, A.5
Chakrabarti, B.6
Hallahan, C.W.7
Migueles, S.A.8
Wrammert, J.9
Ahmed, R.10
Nason, M.11
Wyatt, R.T.12
Mascola, J.R.13
Connors, M.14
-
22
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
-
10.1128/JVI.01762-08, 2583680, 18815292
-
Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, Davis KL, Decker JM, Wycuff D, Harris L, Hawkins N, Wood B, Nathe C, Richman D, Tomaras GD, Bibollet-Ruche F, Robinson JE, Morris L, Shaw GM, Montefiori DC, Mascola JR. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol 2008, 82:11651-11668. 10.1128/JVI.01762-08, 2583680, 18815292.
-
(2008)
J Virol
, vol.82
, pp. 11651-11668
-
-
Binley, J.M.1
Lybarger, E.A.2
Crooks, E.T.3
Seaman, M.S.4
Gray, E.5
Davis, K.L.6
Decker, J.M.7
Wycuff, D.8
Harris, L.9
Hawkins, N.10
Wood, B.11
Nathe, C.12
Richman, D.13
Tomaras, G.D.14
Bibollet-Ruche, F.15
Robinson, J.E.16
Morris, L.17
Shaw, G.M.18
Montefiori, D.C.19
Mascola, J.R.20
more..
-
23
-
-
67650453747
-
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm
-
10.1128/JVI.00110-09, 2704778, 19439467
-
Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol 2009, 83:7337-7348. 10.1128/JVI.00110-09, 2704778, 19439467.
-
(2009)
J Virol
, vol.83
, pp. 7337-7348
-
-
Simek, M.D.1
Rida, W.2
Priddy, F.H.3
Pung, P.4
Carrow, E.5
Laufer, D.S.6
Lehrman, J.K.7
Boaz, M.8
Tarragona-Fiol, T.9
Miiro, G.10
Birungi, J.11
Pozniak, A.12
McPhee, D.A.13
Manigart, O.14
Karita, E.15
Inwoley, A.16
Jaoko, W.17
Dehovitz, J.18
Bekker, L.G.19
Pitisuttithum, P.20
Paris, R.21
Walker, L.M.22
Poignard, P.23
Wrin, T.24
Fast, P.E.25
Burton, D.R.26
Koff, W.C.27
more..
-
24
-
-
77952311370
-
The role of antibodies in HIV vaccines
-
10.1146/annurev-immunol-030409-101256, 20192810
-
Mascola JR, Montefiori DC. The role of antibodies in HIV vaccines. Annu Rev Immunol 2010, 28:413-444. 10.1146/annurev-immunol-030409-101256, 20192810.
-
(2010)
Annu Rev Immunol
, vol.28
, pp. 413-444
-
-
Mascola, J.R.1
Montefiori, D.C.2
-
25
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV- 1 by a recombinant human monoclonal antibody
-
10.1126/science.7973652, 7973652
-
Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL. Efficient neutralization of primary isolates of HIV- 1 by a recombinant human monoclonal antibody. Science 1994, 266:1024-1027. 10.1126/science.7973652, 7973652.
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
Pyati, J.2
Koduri, R.3
Sharp, S.J.4
Thornton, G.B.5
Parren, P.W.6
Sawyer, L.S.7
Hendry, R.M.8
Dunlop, N.9
Nara, P.L.10
-
26
-
-
8644251891
-
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
-
10.1128/JVI.78.23.13232-13252.2004, 524984, 15542675
-
Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J Virol 2004, 78:13232-13252. 10.1128/JVI.78.23.13232-13252.2004, 524984, 15542675.
-
(2004)
J Virol
, vol.78
, pp. 13232-13252
-
-
Binley, J.M.1
Wrin, T.2
Korber, B.3
Zwick, M.B.4
Wang, M.5
Chappey, C.6
Stiegler, G.7
Kunert, R.8
Zolla-Pazner, S.9
Katinger, H.10
Petropoulos, C.J.11
Burton, D.R.12
-
27
-
-
60749124402
-
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India
-
10.1016/j.virol.2008.12.032, 2677301, 19167740
-
Kulkarni SS, Lapedes A, Tang H, Gnanakaran S, Daniels MG, Zhang M, Bhattacharya T, Li M, Polonis VR, McCutchan FE, Morris L, Ellenberger D, Butera ST, Bollinger RC, Korber BT, Paranjape RS, Montefiori DC. Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India. Virology 2009, 385:505-520. 10.1016/j.virol.2008.12.032, 2677301, 19167740.
-
(2009)
Virology
, vol.385
, pp. 505-520
-
-
Kulkarni, S.S.1
Lapedes, A.2
Tang, H.3
Gnanakaran, S.4
Daniels, M.G.5
Zhang, M.6
Bhattacharya, T.7
Li, M.8
Polonis, V.R.9
McCutchan, F.E.10
Morris, L.11
Ellenberger, D.12
Butera, S.T.13
Bollinger, R.C.14
Korber, B.T.15
Paranjape, R.S.16
Montefiori, D.C.17
-
28
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
189917, 8551569
-
Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996, 70:1100-1108. 189917, 8551569.
-
(1996)
J Virol
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
Purtscher, M.2
Muster, T.3
Ballaun, C.4
Buchacher, A.5
Sullivan, N.6
Srinivasan, K.7
Sodroski, J.8
Moore, J.P.9
Katinger, H.10
-
29
-
-
12444291017
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
-
10.1126/science.1083182, 12829775
-
Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 2003, 300:2065-2071. 10.1126/science.1083182, 12829775.
-
(2003)
Science
, vol.300
, pp. 2065-2071
-
-
Calarese, D.A.1
Scanlan, C.N.2
Zwick, M.B.3
Deechongkit, S.4
Mimura, Y.5
Kunert, R.6
Zhu, P.7
Wormald, M.R.8
Stanfield, R.L.9
Roux, K.H.10
Kelly, J.W.11
Rudd, P.M.12
Dwek, R.A.13
Katinger, H.14
Burton, D.R.15
Wilson, I.A.16
-
30
-
-
0028865465
-
Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
-
189569, 7474069
-
Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, Allaway GP, Katinger H, Barbas CF, Burton DR, Ho DD, et al. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 1995, 69:6609-6617. 189569, 7474069.
-
(1995)
J Virol
, vol.69
, pp. 6609-6617
-
-
Trkola, A.1
Pomales, A.B.2
Yuan, H.3
Korber, B.4
Maddon, P.J.5
Allaway, G.P.6
Katinger, H.7
Barbas, C.F.8
Burton, D.R.9
Ho, D.D.10
-
31
-
-
33751224478
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
-
10.1128/JVI.01730-06, 1642599, 16971434
-
Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol 2006, 80:11776-11790. 10.1128/JVI.01730-06, 1642599, 16971434.
-
(2006)
J Virol
, vol.80
, pp. 11776-11790
-
-
Li, M.1
Salazar-Gonzalez, J.F.2
Derdeyn, C.A.3
Morris, L.4
Williamson, C.5
Robinson, J.E.6
Decker, J.M.7
Li, Y.8
Salazar, M.G.9
Polonis, V.R.10
Mlisana, K.11
Karim, S.A.12
Hong, K.13
Greene, K.M.14
Bilska, M.15
Zhou, J.16
Allen, S.17
Chomba, E.18
Mulenga, J.19
Vwalika, C.20
Gao, F.21
Zhang, M.22
Korber, B.T.23
Hunter, E.24
Hahn, B.H.25
Montefiori, D.C.26
more..
-
32
-
-
20844448731
-
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
-
10.1084/jem.20042510, 2213183, 15867093
-
Decker JM, Bibollet-Ruche F, Wei X, Wang S, Levy DN, Wang W, Delaporte E, Peeters M, Derdeyn CA, Allen S, Hunter E, Saag MS, Hoxie JA, Hahn BH, Kwong PD, Robinson JE, Shaw GM. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 2005, 201:1407-1419. 10.1084/jem.20042510, 2213183, 15867093.
-
(2005)
J Exp Med
, vol.201
, pp. 1407-1419
-
-
Decker, J.M.1
Bibollet-Ruche, F.2
Wei, X.3
Wang, S.4
Levy, D.N.5
Wang, W.6
Delaporte, E.7
Peeters, M.8
Derdeyn, C.A.9
Allen, S.10
Hunter, E.11
Saag, M.S.12
Hoxie, J.A.13
Hahn, B.H.14
Kwong, P.D.15
Robinson, J.E.16
Shaw, G.M.17
-
33
-
-
0032543555
-
The antigenic structure of the HIV gp120 envelope glycoprotein
-
10.1038/31514, 9641684
-
Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998, 393:705-711. 10.1038/31514, 9641684.
-
(1998)
Nature
, vol.393
, pp. 705-711
-
-
Wyatt, R.1
Kwong, P.D.2
Desjardins, E.3
Sweet, R.W.4
Robinson, J.5
Hendrickson, W.A.6
Sodroski, J.G.7
-
34
-
-
0027256814
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
-
237765, 7685405
-
Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993, 67:3978-3988. 237765, 7685405.
-
(1993)
J Virol
, vol.67
, pp. 3978-3988
-
-
Thali, M.1
Moore, J.P.2
Furman, C.3
Charles, M.4
Ho, D.D.5
Robinson, J.6
Sodroski, J.7
-
35
-
-
0036436313
-
Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
-
10.1089/08892220260387959, 12487827
-
Xiang SH, Doka N, Choudhary RK, Sodroski J, Robinson JE. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res Hum Retroviruses 2002, 18:1207-1217. 10.1089/08892220260387959, 12487827.
-
(2002)
AIDS Res Hum Retroviruses
, vol.18
, pp. 1207-1217
-
-
Xiang, S.H.1
Doka, N.2
Choudhary, R.K.3
Sodroski, J.4
Robinson, J.E.5
-
36
-
-
0037076265
-
Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
-
10.1073/pnas.102562599, 124503, 11997472
-
Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proc Natl Acad Sci USA 2002, 99:6913-6918. 10.1073/pnas.102562599, 124503, 11997472.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 6913-6918
-
-
Moulard, M.1
Phogat, S.K.2
Shu, Y.3
Labrijn, A.F.4
Xiao, X.5
Binley, J.M.6
Zhang, M.Y.7
Sidorov, I.A.8
Broder, C.C.9
Robinson, J.10
Parren, P.W.11
Burton, D.R.12
Dimitrov, D.S.13
-
37
-
-
13844255333
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
-
10.1016/j.immuni.2004.12.011, 15723805
-
Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005, 22:163-173. 10.1016/j.immuni.2004.12.011, 15723805.
-
(2005)
Immunity
, vol.22
, pp. 163-173
-
-
Cardoso, R.M.1
Zwick, M.B.2
Stanfield, R.L.3
Kunert, R.4
Binley, J.M.5
Katinger, H.6
Burton, D.R.7
Wilson, I.A.8
-
38
-
-
0034759882
-
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
-
10.1128/JVI.75.22.10892-10905.2001, 114669, 11602729
-
Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 2001, 75:10892-10905. 10.1128/JVI.75.22.10892-10905.2001, 114669, 11602729.
-
(2001)
J Virol
, vol.75
, pp. 10892-10905
-
-
Zwick, M.B.1
Labrijn, A.F.2
Wang, M.3
Spenlehauer, C.4
Saphire, E.O.5
Binley, J.M.6
Moore, J.P.7
Stiegler, G.8
Katinger, H.9
Burton, D.R.10
Parren, P.W.11
-
39
-
-
0027378573
-
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type
-
238102, 7692082
-
Muster T, Steindl F, Purtscher M, Trkola A, Klima A, Himmler G, Ruker F, Katinger H. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type. J Virol 1993, 67:6642-6647. 238102, 7692082.
-
(1993)
J Virol
, vol.67
, pp. 6642-6647
-
-
Muster, T.1
Steindl, F.2
Purtscher, M.3
Trkola, A.4
Klima, A.5
Himmler, G.6
Ruker, F.7
Katinger, H.8
-
40
-
-
0038076112
-
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
-
10.1128/JVI.77.10.5678-5684.2003, 154040, 12719560
-
Binley JM, Cayanan CS, Wiley C, Schulke N, Olson WC, Burton DR. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J Virol 2003, 77:5678-5684. 10.1128/JVI.77.10.5678-5684.2003, 154040, 12719560.
-
(2003)
J Virol
, vol.77
, pp. 5678-5684
-
-
Binley, J.M.1
Cayanan, C.S.2
Wiley, C.3
Schulke, N.4
Olson, W.C.5
Burton, D.R.6
-
41
-
-
33644752818
-
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma
-
10.1128/JVI.80.6.3030-3041.2006, 1395451, 16501112
-
Yuste E, Sanford HB, Carmody J, Bixby J, Little S, Zwick MB, Greenough T, Burton DR, Richman DD, Desrosiers RC, Johnson WE. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol 2006, 80:3030-3041. 10.1128/JVI.80.6.3030-3041.2006, 1395451, 16501112.
-
(2006)
J Virol
, vol.80
, pp. 3030-3041
-
-
Yuste, E.1
Sanford, H.B.2
Carmody, J.3
Bixby, J.4
Little, S.5
Zwick, M.B.6
Greenough, T.7
Burton, D.R.8
Richman, D.D.9
Desrosiers, R.C.10
Johnson, W.E.11
-
42
-
-
69249208675
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
-
10.1128/JVI.00758-09, 2738176, 19553335
-
Gray ES, Taylor N, Wycuff D, Moore PL, Tomaras GD, Wibmer CK, Puren A, DeCamp A, Gilbert PB, Wood B, Montefiori DC, Binley JM, Shaw GM, Haynes BF, Mascola JR, Morris L. Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J Virol 2009, 83:8925-8937. 10.1128/JVI.00758-09, 2738176, 19553335.
-
(2009)
J Virol
, vol.83
, pp. 8925-8937
-
-
Gray, E.S.1
Taylor, N.2
Wycuff, D.3
Moore, P.L.4
Tomaras, G.D.5
Wibmer, C.K.6
Puren, A.7
DeCamp, A.8
Gilbert, P.B.9
Wood, B.10
Montefiori, D.C.11
Binley, J.M.12
Shaw, G.M.13
Haynes, B.F.14
Mascola, J.R.15
Morris, L.16
-
43
-
-
0025267919
-
Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
-
10.1097/00002030-199002000-00002, 2328092
-
Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, Nystrom G, Fenyo EM. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. Aids 1990, 4:107-112. 10.1097/00002030-199002000-00002, 2328092.
-
(1990)
Aids
, vol.4
, pp. 107-112
-
-
Albert, J.1
Abrahamsson, B.2
Nagy, K.3
Aurelius, E.4
Gaines, H.5
Nystrom, G.6
Fenyo, E.M.7
-
44
-
-
0037456827
-
Antibody neutralization and escape by HIV-1
-
10.1038/nature01470, 12646921
-
Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. Antibody neutralization and escape by HIV-1. Nature 2003, 422:307-312. 10.1038/nature01470, 12646921.
-
(2003)
Nature
, vol.422
, pp. 307-312
-
-
Wei, X.1
Decker, J.M.2
Wang, S.3
Hui, H.4
Kappes, J.C.5
Wu, X.6
Salazar-Gonzalez, J.F.7
Salazar, M.G.8
Kilby, J.M.9
Saag, M.S.10
Komarova, N.L.11
Nowak, M.A.12
Hahn, B.H.13
Kwong, P.D.14
Shaw, G.M.15
-
45
-
-
49149118421
-
Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection
-
10.1128/JVI.00757-08, 2519599, 18524815
-
Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J Virol 2008, 82:7932-7941. 10.1128/JVI.00757-08, 2519599, 18524815.
-
(2008)
J Virol
, vol.82
, pp. 7932-7941
-
-
Bunnik, E.M.1
Pisas, L.2
van Nuenen, A.C.3
Schuitemaker, H.4
-
46
-
-
38849090714
-
The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection
-
10.1128/JVI.02187-07, 2258729, 18057243
-
Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L. The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol 2008, 82:1860-1869. 10.1128/JVI.02187-07, 2258729, 18057243.
-
(2008)
J Virol
, vol.82
, pp. 1860-1869
-
-
Moore, P.L.1
Gray, E.S.2
Choge, I.A.3
Ranchobe, N.4
Mlisana, K.5
Abdool Karim, S.S.6
Williamson, C.7
Morris, L.8
-
47
-
-
64949147882
-
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination
-
10.1016/j.virol.2009.02.022, 2792036, 19298995
-
Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology 2009, 387:414-26. 10.1016/j.virol.2009.02.022, 2792036, 19298995.
-
(2009)
Virology
, vol.387
, pp. 414-426
-
-
Davis, K.L.1
Gray, E.S.2
Moore, P.L.3
Decker, J.M.4
Salomon, A.5
Montefiori, D.C.6
Graham, B.S.7
Keefer, M.C.8
Pinter, A.9
Morris, L.10
Hahn, B.H.11
Shaw, G.M.12
-
48
-
-
66049139947
-
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
-
10.1084/jem.20090378, 2715054, 19487424
-
Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009, 206:1273-1289. 10.1084/jem.20090378, 2715054, 19487424.
-
(2009)
J Exp Med
, vol.206
, pp. 1273-1289
-
-
Salazar-Gonzalez, J.F.1
Salazar, M.G.2
Keele, B.F.3
Learn, G.H.4
Giorgi, E.E.5
Li, H.6
Decker, J.M.7
Wang, S.8
Baalwa, J.9
Kraus, M.H.10
Parrish, N.F.11
Shaw, K.S.12
Guffey, M.B.13
Bar, K.J.14
Davis, K.L.15
Ochsenbauer-Jambor, C.16
Kappes, J.C.17
Saag, M.S.18
Cohen, M.S.19
Mulenga, J.20
Derdeyn, C.A.21
Allen, S.22
Hunter, E.23
Markowitz, M.24
Hraber, P.25
Perelson, A.S.26
Bhattacharya, T.27
Haynes, B.F.28
Korber, B.T.29
Hahn, B.H.30
Shaw, G.M.31
more..
-
49
-
-
33846552274
-
Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection
-
10.1128/JVI.01839-06, 1797511, 17079307
-
Rong R, Bibollet-Ruche F, Mulenga J, Allen S, Blackwell JL, Derdeyn CA. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol 2007, 81:1350-1359. 10.1128/JVI.01839-06, 1797511, 17079307.
-
(2007)
J Virol
, vol.81
, pp. 1350-1359
-
-
Rong, R.1
Bibollet-Ruche, F.2
Mulenga, J.3
Allen, S.4
Blackwell, J.L.5
Derdeyn, C.A.6
-
50
-
-
34249789875
-
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1
-
10.1128/JVI.00257-07, 1900276, 17360739
-
Rong R, Gnanakaran S, Decker JM, Bibollet-Ruche F, Taylor J, Sfakianos JN, Mokili JL, Muldoon M, Mulenga J, Allen S, Hahn BH, Shaw GM, Blackwell JL, Korber BT, Hunter E, Derdeyn CA. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol 2007, 81:5658-5668. 10.1128/JVI.00257-07, 1900276, 17360739.
-
(2007)
J Virol
, vol.81
, pp. 5658-5668
-
-
Rong, R.1
Gnanakaran, S.2
Decker, J.M.3
Bibollet-Ruche, F.4
Taylor, J.5
Sfakianos, J.N.6
Mokili, J.L.7
Muldoon, M.8
Mulenga, J.9
Allen, S.10
Hahn, B.H.11
Shaw, G.M.12
Blackwell, J.L.13
Korber, B.T.14
Hunter, E.15
Derdeyn, C.A.16
-
51
-
-
70349686331
-
Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection
-
10.1371/journal.ppat.1000598, 2742164, 19763271
-
Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, Abrahams MR, Bandawe G, Mlisana K, Abdool Karim SS, Williamson C, Morris L. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog 2009, 5:e1000598. 10.1371/journal.ppat.1000598, 2742164, 19763271.
-
(2009)
PLoS Pathog
, vol.5
-
-
Moore, P.L.1
Ranchobe, N.2
Lambson, B.E.3
Gray, E.S.4
Cave, E.5
Abrahams, M.R.6
Bandawe, G.7
Mlisana, K.8
Abdool Karim, S.S.9
Williamson, C.10
Morris, L.11
-
52
-
-
70349695689
-
Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways
-
10.1371/journal.ppat.1000594, 2741593, 19763269
-
Rong R, Li B, Lynch RM, Haaland RE, Murphy MK, Mulenga J, Allen SA, Pinter A, Shaw GM, Hunter E, Robinson JE, Gnanakaran S, Derdeyn CA. Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways. PLoS Pathog 2009, 5:e1000594. 10.1371/journal.ppat.1000594, 2741593, 19763269.
-
(2009)
PLoS Pathog
, vol.5
-
-
Rong, R.1
Li, B.2
Lynch, R.M.3
Haaland, R.E.4
Murphy, M.K.5
Mulenga, J.6
Allen, S.A.7
Pinter, A.8
Shaw, G.M.9
Hunter, E.10
Robinson, J.E.11
Gnanakaran, S.12
Derdeyn, C.A.13
-
53
-
-
0038082126
-
Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1
-
10.1128/JVI.77.14.8061-8071.2003, 161940, 12829845
-
Bouma P, Leavitt M, Zhang PF, Sidorov IA, Dimitrov DS, Quinnan GV. Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1. J Virol 2003, 77:8061-8071. 10.1128/JVI.77.14.8061-8071.2003, 161940, 12829845.
-
(2003)
J Virol
, vol.77
, pp. 8061-8071
-
-
Bouma, P.1
Leavitt, M.2
Zhang, P.F.3
Sidorov, I.A.4
Dimitrov, D.S.5
Quinnan, G.V.6
-
54
-
-
0030025979
-
Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells
-
189949, 8551601
-
Carrillo A, Ratner L. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells. J Virol 1996, 70:1310-1316. 189949, 8551601.
-
(1996)
J Virol
, vol.70
, pp. 1310-1316
-
-
Carrillo, A.1
Ratner, L.2
-
55
-
-
0033033625
-
Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
-
112584, 10364275
-
Cheng-Mayer C, Brown A, Harouse J, Luciw PA, Mayer AJ. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J Virol 1999, 73:5294-5300. 112584, 10364275.
-
(1999)
J Virol
, vol.73
, pp. 5294-5300
-
-
Cheng-Mayer, C.1
Brown, A.2
Harouse, J.3
Luciw, P.A.4
Mayer, A.J.5
-
56
-
-
0028322510
-
Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4
-
10.1007/BF01310789, 7832633
-
Gram GJ, Hemming A, Bolmstedt A, Jansson B, Olofsson S, Akerblom L, Nielsen JO, Hansen JE. Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Arch Virol 1994, 139:253-261. 10.1007/BF01310789, 7832633.
-
(1994)
Arch Virol
, vol.139
, pp. 253-261
-
-
Gram, G.J.1
Hemming, A.2
Bolmstedt, A.3
Jansson, B.4
Olofsson, S.5
Akerblom, L.6
Nielsen, J.O.7
Hansen, J.E.8
-
57
-
-
0028293281
-
Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
-
236701, 8139010
-
Koito A, Harrowe G, Levy JA, Cheng-Mayer C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 1994, 68:2253-2259. 236701, 8139010.
-
(1994)
J Virol
, vol.68
, pp. 2253-2259
-
-
Koito, A.1
Harrowe, G.2
Levy, J.A.3
Cheng-Mayer, C.4
-
58
-
-
0035100868
-
Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
-
10.1128/JVI.75.7.3435-3443.2001, 114136, 11238869
-
Kolchinsky P, Kiprilov E, Bartley P, Rubinstein R, Sodroski J. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. J Virol 2001, 75:3435-3443. 10.1128/JVI.75.7.3435-3443.2001, 114136, 11238869.
-
(2001)
J Virol
, vol.75
, pp. 3435-3443
-
-
Kolchinsky, P.1
Kiprilov, E.2
Bartley, P.3
Rubinstein, R.4
Sodroski, J.5
-
59
-
-
0035162494
-
Evolutionary and immunological implications of contemporary HIV-1 variation
-
10.1093/bmb/58.1.19, 11714622
-
Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001, 58:19-42. 10.1093/bmb/58.1.19, 11714622.
-
(2001)
Br Med Bull
, vol.58
, pp. 19-42
-
-
Korber, B.1
Gaschen, B.2
Yusim, K.3
Thakallapally, R.4
Kesmir, C.5
Detours, V.6
-
60
-
-
0030694769
-
The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism
-
10.1089/aid.1997.13.1291, 9339846
-
Morikita T, Maeda Y, Fujii S, Matsushita S, Obaru K, Takatsuki K. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. AIDS Res Hum Retroviruses 1997, 13:1291-1299. 10.1089/aid.1997.13.1291, 9339846.
-
(1997)
AIDS Res Hum Retroviruses
, vol.13
, pp. 1291-1299
-
-
Morikita, T.1
Maeda, Y.2
Fujii, S.3
Matsushita, S.4
Obaru, K.5
Takatsuki, K.6
-
61
-
-
0028321596
-
Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers
-
10.1172/JCI117260, 294468, 7515393
-
Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers. J Clin Invest 1994, 93:2505-2513. 10.1172/JCI117260, 294468, 7515393.
-
(1994)
J Clin Invest
, vol.93
, pp. 2505-2513
-
-
Pincus, S.H.1
Messer, K.G.2
Nara, P.L.3
Blattner, W.A.4
Colclough, G.5
Reitz, M.6
-
62
-
-
0035035296
-
Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein
-
10.1128/JVI.75.11.5230-5239.2001, 114929, 11333905
-
Edwards TG, Hoffman TL, Baribaud F, Wyss S, LaBranche CC, Romano J, Adkinson J, Sharron M, Hoxie JA, Doms RW. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 2001, 75:5230-5239. 10.1128/JVI.75.11.5230-5239.2001, 114929, 11333905.
-
(2001)
J Virol
, vol.75
, pp. 5230-5239
-
-
Edwards, T.G.1
Hoffman, T.L.2
Baribaud, F.3
Wyss, S.4
LaBranche, C.C.5
Romano, J.6
Adkinson, J.7
Sharron, M.8
Hoxie, J.A.9
Doms, R.W.10
-
63
-
-
0035038932
-
Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120
-
10.1128/JVI.75.11.5425-5428.2001, 114953, 11333929
-
Dumonceaux J, Goujon C, Joliot V, Briand P, Hazan U. Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120. J Virol 2001, 75:5425-5428. 10.1128/JVI.75.11.5425-5428.2001, 114953, 11333929.
-
(2001)
J Virol
, vol.75
, pp. 5425-5428
-
-
Dumonceaux, J.1
Goujon, C.2
Joliot, V.3
Briand, P.4
Hazan, U.5
-
64
-
-
0034813198
-
A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression
-
10.1016/S0166-0934(01)00373-1, 11576641
-
Joliot V, Goujon C, Dumonceaux J, Renard A, Briand P, Hazan U. A human immunodeficiency virus Env inducible transcription system to examine consequences of gp120 expression. J Virol Methods 2001, 98:145-151. 10.1016/S0166-0934(01)00373-1, 11576641.
-
(2001)
J Virol Methods
, vol.98
, pp. 145-151
-
-
Joliot, V.1
Goujon, C.2
Dumonceaux, J.3
Renard, A.4
Briand, P.5
Hazan, U.6
-
65
-
-
55649084842
-
The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors
-
10.1186/1742-4690-5-89, 2576352, 18837996
-
Rossi F, Querido B, Nimmagadda M, Cocklin S, Navas-Martin S, Martin-Garcia J. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors. Retrovirology 2008, 5:89. 10.1186/1742-4690-5-89, 2576352, 18837996.
-
(2008)
Retrovirology
, vol.5
, pp. 89
-
-
Rossi, F.1
Querido, B.2
Nimmagadda, M.3
Cocklin, S.4
Navas-Martin, S.5
Martin-Garcia, J.6
-
66
-
-
0034631503
-
Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
-
10.1016/S0140-6736(00)02360-6, 10885368
-
Esparza J, Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?. Lancet 2000, 355:2061-2066. 10.1016/S0140-6736(00)02360-6, 10885368.
-
(2000)
Lancet
, vol.355
, pp. 2061-2066
-
-
Esparza, J.1
Bhamarapravati, N.2
-
67
-
-
0034978733
-
Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
-
10.1128/JVI.75.13.5721-5729.2001, 114288, 11390574
-
Moore JP, Parren PW, Burton DR. Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001, 75:5721-5729. 10.1128/JVI.75.13.5721-5729.2001, 114288, 11390574.
-
(2001)
J Virol
, vol.75
, pp. 5721-5729
-
-
Moore, J.P.1
Parren, P.W.2
Burton, D.R.3
-
68
-
-
0036471553
-
Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000
-
Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002, 29:184-190.
-
(2002)
J Acquir Immune Defic Syndr
, vol.29
, pp. 184-190
-
-
Osmanov, S.1
Pattou, C.2
Walker, N.3
Schwardlander, B.4
Esparza, J.5
-
69
-
-
0034796179
-
Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences
-
75, 10.1128/JVI.75.21.10479-10487.2001, 114623, 11581417
-
Shankarappa R, Chatterjee R, Learn GH, Neogi D, Ding M, Roy P, Ghosh A, Kingsley L, Harrison L, Mullins JI, Gupta P. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J Virol 2001, 75:10479-10487. 75, 10.1128/JVI.75.21.10479-10487.2001, 114623, 11581417.
-
(2001)
J Virol
, vol.75
, pp. 10479-10487
-
-
Shankarappa, R.1
Chatterjee, R.2
Learn, G.H.3
Neogi, D.4
Ding, M.5
Roy, P.6
Ghosh, A.7
Kingsley, L.8
Harrison, L.9
Mullins, J.I.10
Gupta, P.11
-
70
-
-
0001792727
-
Recombinant HIV sequences: their role in the global epidemic
-
Los Alamos National Laboratory, Los Alamos, N Mex, Kuiken FB, Hahn CB, Marx P, McCutchan F, Mellors J, Mullins J, Sodroski J, Wolinksy S, Korber B
-
Peeters M. Recombinant HIV sequences: their role in the global epidemic. HIV sequence compendium 2000 Theoretical Biology and Biophysics Group 2000, 39-54. Los Alamos National Laboratory, Los Alamos, N Mex, Kuiken FB, Hahn CB, Marx P, McCutchan F, Mellors J, Mullins J, Sodroski J, Wolinksy S, Korber B.
-
(2000)
HIV sequence compendium 2000 Theoretical Biology and Biophysics Group
, pp. 39-54
-
-
Peeters, M.1
-
71
-
-
39749136530
-
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response
-
10.1128/JVI.02161-07, 2258954, 18094155
-
Gray ES, Moore PL, Bibollet-Ruche F, Li H, Decker JM, Meyers T, Shaw GM, Morris L. 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response. J Virol 2008, 82:2367-2375. 10.1128/JVI.02161-07, 2258954, 18094155.
-
(2008)
J Virol
, vol.82
, pp. 2367-2375
-
-
Gray, E.S.1
Moore, P.L.2
Bibollet-Ruche, F.3
Li, H.4
Decker, J.M.5
Meyers, T.6
Shaw, G.M.7
Morris, L.8
-
72
-
-
34648816125
-
N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
-
10.1128/JVI.01106-07, 2045459, 17634239
-
Gray ES, Moore PL, Pantophlet RA, Morris L. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization. J Virol 2007, 81:10769-10776. 10.1128/JVI.01106-07, 2045459, 17634239.
-
(2007)
J Virol
, vol.81
, pp. 10769-10776
-
-
Gray, E.S.1
Moore, P.L.2
Pantophlet, R.A.3
Morris, L.4
-
73
-
-
33645101026
-
Molecular analysis of gp41 sequences of HIV type 1 subtype C from India
-
10.1097/01.qai.0000209898.67007.1a, 16540936
-
Agnihotri KD, Tripathy SP, Jere AP, Kale SM, Paranjape RS. Molecular analysis of gp41 sequences of HIV type 1 subtype C from India. J Acquir Immune Defic Syndr 2006, 41:345-351. 10.1097/01.qai.0000209898.67007.1a, 16540936.
-
(2006)
J Acquir Immune Defic Syndr
, vol.41
, pp. 345-351
-
-
Agnihotri, K.D.1
Tripathy, S.P.2
Jere, A.P.3
Kale, S.M.4
Paranjape, R.S.5
-
74
-
-
1542268337
-
Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications
-
10.1016/j.micinf.2003.11.012, 15026015
-
Jere A, Tripathy S, Agnihotri K, Jadhav S, Paranjape R. Genetic analysis of Indian HIV-1 nef: subtyping, variability and implications. Microbes Infect 2004, 6:279-289. 10.1016/j.micinf.2003.11.012, 15026015.
-
(2004)
Microbes Infect
, vol.6
, pp. 279-289
-
-
Jere, A.1
Tripathy, S.2
Agnihotri, K.3
Jadhav, S.4
Paranjape, R.5
-
75
-
-
6344241307
-
Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India
-
10.1089/aid.2004.20.1113, 15585103
-
Kurle S, Tripathy S, Jadhav S, Agnihotri K, Paranjape R. Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res Hum Retroviruses 2004, 20:1113-1118. 10.1089/aid.2004.20.1113, 15585103.
-
(2004)
AIDS Res Hum Retroviruses
, vol.20
, pp. 1113-1118
-
-
Kurle, S.1
Tripathy, S.2
Jadhav, S.3
Agnihotri, K.4
Paranjape, R.5
-
76
-
-
4344633809
-
Gp120 sequences from HIV type 1 subtype C early seroconverters in India
-
Agnihorti K, Tripathy S, Jere A, Jadhav S, Kurle S, Paranjape R. gp120 sequences from HIV type 1 subtype C early seroconverters in India. AIDS Res HumRetroviruses 2004, 20:889-894.
-
(2004)
AIDS Res HumRetroviruses
, vol.20
, pp. 889-894
-
-
Agnihorti, K.1
Tripathy, S.2
Jere, A.3
Jadhav, S.4
Kurle, S.5
Paranjape, R.6
-
77
-
-
34547930926
-
Genetic diversity of HIV type 1 subtype C env gene sequences from India
-
10.1089/aid.2007.0036, 17678478
-
Khan IF, Vajpayee M, Prasad VV, Seth P. Genetic diversity of HIV type 1 subtype C env gene sequences from India. AIDS Res Hum Retroviruses 2007, 23:934-940. 10.1089/aid.2007.0036, 17678478.
-
(2007)
AIDS Res Hum Retroviruses
, vol.23
, pp. 934-940
-
-
Khan, I.F.1
Vajpayee, M.2
Prasad, V.V.3
Seth, P.4
-
78
-
-
77956325565
-
4E10-Resistant HIV-1 Isolated from Four Subjects with Rare Membrane-Proximal External Region Polymorphisms
-
10.1371/journal.pone.0009786, 2843716, 20352106
-
Nakamura K, Gach JS, Jones L, Semrau K, Walter J, Bibollet-Ruche F, Decker JM, Heath L, Decker WD, Sinkala M, Kankasa C, Thea D, Mullins J, Kuhn L, Zwick MB, Aldrovand GM. 4E10-Resistant HIV-1 Isolated from Four Subjects with Rare Membrane-Proximal External Region Polymorphisms. PLoS One 2010, 5(3):e9786. 10.1371/journal.pone.0009786, 2843716, 20352106.
-
(2010)
PLoS One
, vol.5
, Issue.3
-
-
Nakamura, K.1
Gach, J.S.2
Jones, L.3
Semrau, K.4
Walter, J.5
Bibollet-Ruche, F.6
Decker, J.M.7
Heath, L.8
Decker, W.D.9
Sinkala, M.10
Kankasa, C.11
Thea, D.12
Mullins, J.13
Kuhn, L.14
Zwick, M.B.15
Aldrovand, G.M.16
-
79
-
-
41149099165
-
Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors
-
2268948, 18205925
-
Peters PJ, Duenas-Decamp MJ, Sullivan WM, Brown R, Ankghuambom C, Luzuriaga K, Robinson J, Burton DR, Bell J, Simmonds P, Ball J, Clapham PR. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology 2008, 5:5. 2268948, 18205925.
-
(2008)
Retrovirology
, vol.5
, pp. 5
-
-
Peters, P.J.1
Duenas-Decamp, M.J.2
Sullivan, W.M.3
Brown, R.4
Ankghuambom, C.5
Luzuriaga, K.6
Robinson, J.7
Burton, D.R.8
Bell, J.9
Simmonds, P.10
Ball, J.11
Clapham, P.R.12
-
80
-
-
68449087500
-
Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12
-
10.1186/1742-4690-6-69, 2717910, 19619305
-
Dunfee RL, Thomas ER, Gabuzda D. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12. Retrovirology 2009, 6:69. 10.1186/1742-4690-6-69, 2717910, 19619305.
-
(2009)
Retrovirology
, vol.6
, pp. 69
-
-
Dunfee, R.L.1
Thomas, E.R.2
Gabuzda, D.3
-
81
-
-
69449095991
-
Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility
-
10.1128/JVI.00648-09, 2738218, 19570853
-
Vermeire K, Van Laethem K, Janssens W, Bell TW, Schols D. Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility. J Virol 2009, 83:9577-9583. 10.1128/JVI.00648-09, 2738218, 19570853.
-
(2009)
J Virol
, vol.83
, pp. 9577-9583
-
-
Vermeire, K.1
Van Laethem, K.2
Janssens, W.3
Bell, T.W.4
Schols, D.5
-
82
-
-
0036114281
-
Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate
-
10.1128/JVI.76.12.6277-6292.2002, 136234, 12021361
-
Gorry PR, Taylor J, Holm GH, Mehle A, Morgan T, Cayabyab M, Farzan M, Wang H, Bell JE, Kunstman K, Moore JP, Wolinsky SM, Gabuzda D. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol 2002, 76:6277-6292. 10.1128/JVI.76.12.6277-6292.2002, 136234, 12021361.
-
(2002)
J Virol
, vol.76
, pp. 6277-6292
-
-
Gorry, P.R.1
Taylor, J.2
Holm, G.H.3
Mehle, A.4
Morgan, T.5
Cayabyab, M.6
Farzan, M.7
Wang, H.8
Bell, J.E.9
Kunstman, K.10
Moore, J.P.11
Wolinsky, S.M.12
Gabuzda, D.13
-
83
-
-
33750036975
-
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
-
10.1073/pnas.0605513103, 1586182, 17015824
-
Dunfee RL, Thomas ER, Gorry PR, Wang J, Taylor J, Kunstman K, Wolinsky SM, Gabuzda D. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci USA 2006, 103:15160-15165. 10.1073/pnas.0605513103, 1586182, 17015824.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 15160-15165
-
-
Dunfee, R.L.1
Thomas, E.R.2
Gorry, P.R.3
Wang, J.4
Taylor, J.5
Kunstman, K.6
Wolinsky, S.M.7
Gabuzda, D.8
-
84
-
-
2942687021
-
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages
-
10.1128/JVI.78.13.6915-6926.2004, 421670, 15194768
-
Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, Bell J, Simmonds P, Clapham PR. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 2004, 78:6915-6926. 10.1128/JVI.78.13.6915-6926.2004, 421670, 15194768.
-
(2004)
J Virol
, vol.78
, pp. 6915-6926
-
-
Peters, P.J.1
Bhattacharya, J.2
Hibbitts, S.3
Dittmar, M.T.4
Simmons, G.5
Bell, J.6
Simmonds, P.7
Clapham, P.R.8
-
85
-
-
0036210446
-
Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence
-
10.1089/088922202753472874, 11860677
-
Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002, 18:295-307. 10.1089/088922202753472874, 11860677.
-
(2002)
AIDS Res Hum Retroviruses
, vol.18
, pp. 295-307
-
-
Parekh, B.S.1
Kennedy, M.S.2
Dobbs, T.3
Pau, C.P.4
Byers, R.5
Green, T.6
Hu, D.J.7
Vanichseni, S.8
Young, N.L.9
Choopanya, K.10
Mastro, T.D.11
McDougal, J.S.12
-
86
-
-
0035139698
-
Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection
-
10.1089/08892220150217229, 11177393
-
Parekh BS, Pau CP, Kennedy MS, Dobbs TL, McDougal JS. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001, 17:137-146. 10.1089/08892220150217229, 11177393.
-
(2001)
AIDS Res Hum Retroviruses
, vol.17
, pp. 137-146
-
-
Parekh, B.S.1
Pau, C.P.2
Kennedy, M.S.3
Dobbs, T.L.4
McDougal, J.S.5
-
87
-
-
23044447788
-
Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries
-
10.1097/01.aids.0000172874.90133.7a, 15930838
-
McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. Aids 2005, 19(Suppl 2):S25-30. 10.1097/01.aids.0000172874.90133.7a, 15930838.
-
(2005)
Aids
, vol.19
, Issue.SUPPL. 2
-
-
McDougal, J.S.1
Pilcher, C.D.2
Parekh, B.S.3
Gershy-Damet, G.4
Branson, B.M.5
Marsh, K.6
Wiktor, S.Z.7
-
88
-
-
38149079942
-
Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin
-
10.1089/aid.2007.0214, 18275353
-
Lakhashe S, Tripathy S, Paranjape R, Bhattacharya J. Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res Hum Retroviruses 2008, 24:92-99. 10.1089/aid.2007.0214, 18275353.
-
(2008)
AIDS Res Hum Retroviruses
, vol.24
, pp. 92-99
-
-
Lakhashe, S.1
Tripathy, S.2
Paranjape, R.3
Bhattacharya, J.4
-
89
-
-
0036090585
-
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
-
10.1128/AAC.46.6.1896-1905.2002, 127242, 12019106
-
Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002, 46:1896-1905. 10.1128/AAC.46.6.1896-1905.2002, 127242, 12019106.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1896-1905
-
-
Wei, X.1
Decker, J.M.2
Liu, H.3
Zhang, Z.4
Arani, R.B.5
Kilby, J.M.6
Saag, M.S.7
Wu, X.8
Shaw, G.M.9
Kappes, J.C.10
-
90
-
-
23244434512
-
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
-
10.1128/JVI.79.16.10108-10125.2005, 1182643, 16051804
-
Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005, 79:10108-10125. 10.1128/JVI.79.16.10108-10125.2005, 1182643, 16051804.
-
(2005)
J Virol
, vol.79
, pp. 10108-10125
-
-
Li, M.1
Gao, F.2
Mascola, J.R.3
Stamatatos, L.4
Polonis, V.R.5
Koutsoukos, M.6
Voss, G.7
Goepfert, P.8
Gilbert, P.9
Greene, K.M.10
Bilska, M.11
Kothe, D.L.12
Salazar-Gonzalez, J.F.13
Wei, X.14
Decker, J.M.15
Hahn, B.H.16
Montefiori, D.C.17
|